Apollo Hospitals Group joins International Initiative for Transforming Global Healthcare

National:  The Apollo Hospitals group is forever expanding the horizon of healthcare. Now it has joined International force to bring about transformation of global healthcare. With this end in view, Indian Healthcare major has inked a Memorandum Of Understanding (MOU) with University of Leicester.

 The Memorandum will strengthen existing links with the UK and sets out a mutual desire to promote international cooperation and explore collaborative education and research programmers, particularly in the fields of healthcare management, healthcare and data science.

Ms. Preetha Reddy, Vice Chairperson of the Apollo Hospitals Group, said‘We are delighted to have this agreement with the University of Leicester (UoL) in place to explore the creation of education programmes, cutting edge research and global mobility opportunities for Indian students to excel in their area of interest. Building a healthcare workforce to global standards has been the cornerstone of Apollo’s education and skilling initiatives. Working with the University of Leicester builds on the legacy of collaboration between India and the UK and will lead to finding newer solutions to tackle global healthcare challenges while addressing the shortage of skilled workforce in India and the UK.’

President and Vice-Chancellor of the University of Leicester, Professor Nishan Canagarajah, said: “The purpose of this Memorandum of Understanding is to set out a vision to help to build the healthcare of the future with the potential to transform lives, not only in India and the UK, but around the globe.

“Apollo is a pioneering organisation and has led the way in Asia with a number of firsts including the first heart transplantation in 1995. At Leicester, our long-established expertise in health means together we can create more world firsts in healthcare.

“The potential of this Collaboration cannot be underestimated, we can be at the cutting edge of the degree programmes of the future, offering opportunities that will enrich the experience of students and academics in both countries, new research partnerships in precision medicine, and collaborating to find new and novel ways to solve the biggest challenges in health. I am delighted that we have taken this first step towards a closer working relationship.”

The University of Leicester leads the UK in respiratory, cardiovascular and diabetes research, ranking 2nd to Cambridge and joint with UCL, for research in Clinical Medicine, based on analysis of the Research Excellence Framework 2021 undertaken by the Times Higher Education.

As one of only 20 institutions in the UK, the University of Leicester Biomedical Research Centre was awarded £26 million of funding by the National Institute for Health and Care Research. The Biomedical Research Centre will drive clinical research from the laboratory to the patient’s bedside in the areas of; cardiovascular disease; respiratory and infectious diseases; lifestyle and physical activity; personalised cancer prevention and treatments; environment and health; and data innovations in multiple long term health conditions and ethnic health.

Another of the University’s flagship projects is a £10 million initiative led by Professor Kamlesh Kunti which will see the University work with the UK, Indian and Nepalese governments to improve the health outcomes of those with multi morbidity, as well as

create a self-sustaining international centre for improving management of multiple long-term conditions and disseminate outputs globally.

The City of Leicester also has strong links with India with one of Britain’s highest proportions of South Asians, a vast majority of them of Indian heritage, who make up 22 per cent of the overall population.

Related Posts

‘Made in India’ Stents win major victory against Import Lobby

New Delhi/ Ahmadabad: Gujarat’s Department of Health and Family welfare beat a hasty retreat on its biased order against domestic stent makers, thanks to immediate intervention of former Union Health…

Is Gujarat’s Health Department Rebelling against PM Modi Government?

Ahmedabad/ New Delhi: In a move that has stunned the medical industry and political circles alike; the Gujarat Health Department has introduced a differential pricing mechanism for stents under the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

DCA seizes syrup stocks over misleading fever cure claim

DCA seizes syrup stocks over misleading fever cure claim

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease